General Environmental Conservation PCL

The company maintains a strong liquidity position with a current ratio of 3.09 and holds THB 205,337,440 in cash and equivalents, representing 14.9% of total assets. Its debt-to-equity ratio is 0.04, indicating a conservative capital structure with long-term debt accounting for only 3.5% of total equity. Free cash flow of THB 41,502,770 suggests operational efficiency, though capital expenditures of THB -47,444,000 indicate ongoing investment in infrastructure. Profitability metrics show a return on equity of 3.93% and return on assets of 3.14%, both below the median for the Environmental Services & Equipment industry. Operating income of THB 42,376,380 represents 14.4% of revenue, with gross profit margin at 36.2%. These figures suggest moderate profitability relative to industry peers, with room for improvement in cost management and asset utilization. Revenue is concentrated across three primary segments: industrial waste treatment (62% of total revenue), real estate (28%), and medical equipment distribution (10%). Geographically, operations are entirely domestic, with no disclosed international revenue streams. This concentration increases exposure to local economic conditions and regulatory changes. Outlook for FY2024 shows revenue growth of 5.8% year-over-year, driven by expansion in waste treatment capacity and new property development projects. Net income is projected to increase by 4.2%, reflecting improved operational efficiency and higher utilization of existing facilities. These projections align with historical growth rates of 6.1% in revenue and 5.3% in net income over the past three years. Risk assessment indicates low liquidity and dilution risk, with no immediate filing-based flags detected. The company has not issued new shares in the past 12 months, and diluted shares outstanding remain unchanged at 1,108,708,925. No material dilution sources were identified in recent filings or transcripts. Recent events include the completion of a THB 150 million expansion at the Samaedum industrial waste facility and the acquisition of a 49% stake in a medical equipment distributor. These developments were disclosed in the Q3 2023 earnings call and 10-K filing, with no material adverse events reported in the past six months.